1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
EpiCast Report: Head and Neck Cancers - Epidemiology Forecast to 2024

EpiCast Report: Head and Neck Cancers - Epidemiology Forecast to 2024

  • February 2016
  • 80 pages
  • ID: 3664420
In this report:
AS SHOWN IN THE FOLLOWING FIGURE, THE DIAGNOSED INCIDENT CASES OF THYROID CANCER IN THE ##MM ARE EXPECTED TO INCREASE FROM ##,## DIAGNOSED INCIDENT CASES IN 2014 TO ##,## DIAGNOSED INCIDENT CASES IN 2024, WITH AN AGR OF ##.##% DURING THE FORECAST PERIOD.
THE FIVE-YEAR DIAGNOSED PREVALENT CASES OF LARYNX CANCER IN THE ##MM ARE EXPECTED TO INCREASE FROM ##,## CASES IN 2014 TO ##,## CASES IN 2024, WITH AN AGR OF ##.##% DURING THE FORECAST PERIOD.

Summary

Table of Contents

Search Inside

EpiCast Report: Head and Neck Cancers - Epidemiology Forecast to 2024

Brief

Head and neck cancers are a heterogeneous group, consisting of cancers of the mouth, containing the lip, tongue, gum, floor of mouth, palate, and other parts of mouth; the salivary glands; the pharynx, containing the tonsil, oropharynx, nasopharynx, pyriform fossa, hypopharynx, other mouth/pharynx; the nose, sinuses, and related structures; the larynx; and the thyroid. HNCs usually begin in the squamous cells that line the moist mucosal surfaces of the tissues and organs of the head and neck - more than 80.0 percent of all HNCs are squamous cell carcinomas. HNCs are common in different regions across the world and account for 600,000 additional cases annually worldwide.

GlobalData epidemiologists forecast an increase in diagnosed incident cases of HNCs in the 7MM from 151,393 diagnosed incident cases in 2014 to 174,056 diagnosed incident cases in 2024, with an Annual Growth Rate of ~1.5 percent during the forecast period. In 2024, the U.S. will have the more significant number of diagnosed incident cases of HNCs in the 7MM, with 65,663 diagnosed incident cases, whereas the United Kingdom (UK) will have the lowest number of diagnosed incident cases of HNCs, with 12,702 diagnosed incident cases in 2024. The diagnosed incident cases of thyroid cancer in the 7MM are anticipated to increase from 93,225 diagnosed incident cases in 2014 to 123,504 diagnosed incident cases in 2024, with an AGR of ~3.3 percent during the forecast period. In 2024, the U.S. will have the more important number of diagnosed incident cases of thyroid cancer in the 7MM with 81,286 diagnosed incident cases, whereas Spain (ES) will have the lowest number of diagnosed incident cases of thyroid cancer with 3,233 diagnosed incident cases in 2024.

Overview

- The Head and neck cancers EpiCast Report offers an overview of the risk factors, comorbidities, and the overall and historical trends for HNCs in the seven main markets (7MM) (US, France (FR), Germany (DE), Italy (IT), Spain (ES), UK, and Japan (JP)). It includes a 10-year epidemiological forecast of the diagnosed incident cases of HNCs divided into three sub-groups: cancers of the lip, oral cavity, and pharynx; cancers of the nose, sinuses, and related structures; and cancers of the larynx, in these markets. It also includes a 10-year epidemiological forecast for the 5-year diagnosed prevalent cases of HNCs (excluding nose, sinuses, and related cancers). On top of, it includes a 10-year epidemiological forecast for the diagnosed incident cases and the 5-year diagnosed prevalent cases of thyroid cancer in the 7MM. The diagnosed incident cases of HNCs (excluding nose, sinuses, and related cancers) and thyroid cancer are broken down by age, sex, clinical stage at diagnosis, and histology.

- The HNCs epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is detailed, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Great reasons to purchase

The HNCs EpiCast report will allow you to -

- Develop strategic management by understanding the trends shaping and driving the overall HNCs market.

- Quantify patient populations in the overall HNCs market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for HNCs therapeutics in each of the markets covered.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Gastrointestinal / GI Stent Market by Type Material Disease, End User - Global Forecast to 2022

Gastrointestinal / GI Stent Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • December 2017
  • by MarketsandMarkets

The gastrointestinal stents market is projected to grow at a CAGR of 5.1% between 2017 and 2022.The gastrointestinal stents market is expected to reach USD 452.6 million by 2022 from USD 353.4 million ...

Cancer/Tumor Profiling Market by Application, Technique ,Technology - Forecast to 2021

Cancer/Tumor Profiling Market: Forecast until 2021

  • $ 5650
  • Industry report
  • January 2018
  • by MarketsandMarkets

The global cancer/tumor profiling market is projected to grow at a CAGR of 10.7%.Global cancer/tumor profiling market is projected to reach USD 8.74 billion in 2022 from USD 5.26 billion in 2017 at CAGR ...

Gene Therapy for Ovarian Cancer- A Pipeline Analysis Report

Gene Therapy for Ovarian Cancer- A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • January 2018
  • by Infiniti Research Limited

About Gene TherapyOvarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cance ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the Netherlands

  • January 2018
    8 pages
  • Cancer  

  • Netherlands  

    Germany  

View report >

Cancer Statistics in the UK

  • January 2018
    11 pages
  • Molecular Diagn...  

  • United Kingdom  

View report >

Cancer Statistics and Digestive System Disorder Statistics in the UK

  • January 2018
    10 pages
  • Cancer  

    Digestive Syste...  

  • United Kingdom  

View report >

Related Market Segments :

Cancer

Hospital

ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.